Catenin gamma Antibody - #AF0125
製品説明
*The optimal dilutions should be determined by the end user.
*Tips:
WB: For western blot detection of denatured protein samples. IHC: For immunohistochemical detection of paraffin sections (IHC-p) or frozen sections (IHC-f) of tissue samples. IF/ICC: For immunofluorescence detection of cell samples. ELISA(peptide): For ELISA detection of antigenic peptide.
引用形式: Affinity Biosciences Cat# AF0125, RRID:AB_2833309.
折りたたみ/展開
ARVD 12; ARVD12; Catenin (cadherin associated protein), gamma 80kDa; catenin (cadherin-associated protein) gamma (80kD); Catenin gamma; CTNNG; Desmoplakin 3; Desmoplakin III; Desmoplakin-3; Desmoplakin3; DesmoplakinIII; DP 3; DP III; DP3; DPIII; gamma catenin; Junction plakoglobin; JUP; OTTHUMP00000164732; OTTHUMP00000164735; OTTHUMP00000164738; PDGB; PKGB; PLAK_HUMAN; PLAKOGLOBIN;
免疫原
- P14923 PLAK_HUMAN:
- Protein BLAST With
- NCBI/
- ExPASy/
- Uniprot
MEVMNLMEQPIKVTEWQQTYTYDSGIHSGANTCVPSVSSKGIMEEDEACGRQYTLKKTTTYTQGVPPSQGDLEYQMSTTARAKRVREAMCPGVSGEDSSLLLATQVEGQATNLQRLAEPSQLLKSAIVHLINYQDDAELATRALPELTKLLNDEDPVVVTKAAMIVNQLSKKEASRRALMGSPQLVAAVVRTMQNTSDLDTARCTTSILHNLSHHREGLLAIFKSGGIPALVRMLSSPVESVLFYAITTLHNLLLYQEGAKMAVRLADGLQKMVPLLNKNNPKFLAITTDCLQLLAYGNQESKLIILANGGPQALVQIMRNYSYEKLLWTTSRVLKVLSVCPSNKPAIVEAGGMQALGKHLTSNSPRLVQNCLWTLRNLSDVATKQEGLESVLKILVNQLSVDDVNVLTCATGTLSNLTCNNSKNKTLVTQNSGVEALIHAILRAGDKDDITEPAVCALRHLTSRHPEAEMAQNSVRLNYGIPAIVKLLNQPNQWPLVKATIGLIRNLALCPANHAPLQEAAVIPRLVQLLVKAHQDAQRHVAAGTQQPYTDGVRMEEIVEGCTGALHILARDPMNRMEIFRLNTIPLFVQLLYSSVENIQRVAAGVLCELAQDKEAADAIDAEGASAPLMELLHSRNEGTATYAAAVLFRISEDKNPDYRKRVSVELTNSLFKHDPAAWEAAQSMIPINEPYGDDMDATYRPMYSSDVPLDPLEMHMDMDGDYPIDTYSDGLRPPYPTADHMLA
種類予測
Score>80(red) has high confidence and is suggested to be used for WB detection. *The prediction model is mainly based on the alignment of immunogen sequences, the results are for reference only, not as the basis of quality assurance.
High(score>80) Medium(80>score>50) Low(score<50) No confidence
PTMs - P14923 基板として
Site | PTM Type | Enzyme | Source |
---|---|---|---|
M1 | Acetylation | Uniprot | |
T14 | O-Glycosylation | Uniprot | |
T19 | Phosphorylation | Uniprot | |
Y20 | Phosphorylation | Uniprot | |
T21 | Phosphorylation | Uniprot | |
Y22 | Phosphorylation | Uniprot | |
S24 | Phosphorylation | Uniprot | |
K40 | Ubiquitination | Uniprot | |
Y53 | Phosphorylation | Uniprot | |
T54 | Phosphorylation | Uniprot | |
K56 | Ubiquitination | Uniprot | |
K57 | Ubiquitination | Uniprot | |
T58 | Phosphorylation | Uniprot | |
T59 | Phosphorylation | Uniprot | |
T60 | Phosphorylation | Uniprot | |
Y61 | Phosphorylation | Uniprot | |
T62 | Phosphorylation | Uniprot | |
S68 | Phosphorylation | Uniprot | |
Y74 | Phosphorylation | Uniprot | |
S77 | Phosphorylation | Uniprot | |
S94 | Phosphorylation | Uniprot | |
S99 | Phosphorylation | Uniprot | |
T104 | Phosphorylation | Uniprot | |
S120 | Phosphorylation | Uniprot | |
K124 | Ubiquitination | Uniprot | |
S125 | Phosphorylation | Uniprot | |
Y133 | Phosphorylation | P06241 (FYN) | Uniprot |
T141 | Phosphorylation | Uniprot | |
K149 | Ubiquitination | Uniprot | |
T160 | Phosphorylation | Uniprot | |
K161 | Ubiquitination | Uniprot | |
S170 | Phosphorylation | Uniprot | |
K171 | Ubiquitination | Uniprot | |
S182 | Phosphorylation | Uniprot | |
T196 | Phosphorylation | Uniprot | |
S197 | Phosphorylation | Uniprot | |
K224 | Ubiquitination | Uniprot | |
K272 | Ubiquitination | Uniprot | |
K279 | Ubiquitination | Uniprot | |
K326 | Acetylation | Uniprot | |
K336 | Ubiquitination | Uniprot | |
K345 | Ubiquitination | Uniprot | |
K359 | Ubiquitination | Uniprot | |
K385 | Ubiquitination | Uniprot | |
K424 | Ubiquitination | Uniprot | |
K426 | Ubiquitination | Uniprot | |
T430 | Phosphorylation | Uniprot | |
K448 | Ubiquitination | Uniprot | |
T463 | Phosphorylation | Uniprot | |
Y480 | Phosphorylation | Uniprot | |
K499 | Ubiquitination | Uniprot | |
T546 | Phosphorylation | Uniprot | |
Y550 | Phosphorylation | P06241 (FYN) , P16591 (FER) | Uniprot |
T551 | Phosphorylation | Uniprot | |
T564 | Phosphorylation | Uniprot | |
S596 | Phosphorylation | Uniprot | |
Y644 | Phosphorylation | P12931 (SRC) | Uniprot |
Y660 | Phosphorylation | Uniprot | |
S665 | Phosphorylation | Uniprot | |
T669 | Phosphorylation | Uniprot | |
S671 | Phosphorylation | Uniprot | |
Y701 | Phosphorylation | Uniprot | |
Y724 | Phosphorylation | Uniprot | |
T728 | Phosphorylation | Uniprot | |
Y729 | Phosphorylation | Uniprot | |
S730 | Phosphorylation | Uniprot |
研究背景
Common junctional plaque protein. The membrane-associated plaques are architectural elements in an important strategic position to influence the arrangement and function of both the cytoskeleton and the cells within the tissue. The presence of plakoglobin in both the desmosomes and in the intermediate junctions suggests that it plays a central role in the structure and function of submembranous plaques. Acts as a substrate for VE-PTP and is required by it to stimulate VE-cadherin function in endothelial cells. Can replace beta-catenin in E-cadherin/catenin adhesion complexes which are proposed to couple cadherins to the actin cytoskeleton (By similarity).
May be phosphorylated by FER.
Cell junction>Adherens junction. Cell junction>Desmosome. Cytoplasm>Cytoskeleton. Membrane>Peripheral membrane protein.
Note: Cytoplasmic in a soluble and membrane-associated form.
Homodimer. Component of an E-cadherin/catenin adhesion complex composed of at least E-cadherin/CDH1 and gamma-catenin/JUP, and possibly alpha-catenin/CTNNA1; the complex is located to adherens junctions. The stable association of CTNNA1 is controversial as CTNNA1 was shown not to bind to F-actin when assembled in the complex. Interacts with MUC1. Interacts with CAV1 (By similarity). Interacts with PTPRJ. Interacts with DSG1. Interacts with DSC1 and DSC2. Interacts with PKP2.
The entire ARM repeats region mediates binding to CDH1/E-cadherin. The N-terminus and first three ARM repeats are sufficient for binding to DSG1. The N-terminus and first ARM repeat are sufficient for association with CTNNA1. DSC1 association requires both ends of the ARM repeat region.
Belongs to the beta-catenin family.
研究領域
· Human Diseases > Cancers: Overview > Pathways in cancer. (View pathway)
· Human Diseases > Cancers: Overview > Transcriptional misregulation in cancer.
· Human Diseases > Cancers: Specific types > Acute myeloid leukemia. (View pathway)
· Human Diseases > Cancers: Specific types > Gastric cancer. (View pathway)
· Human Diseases > Cardiovascular diseases > Arrhythmogenic right ventricular cardiomyopathy (ARVC).
Restrictive clause
Affinity Biosciences tests all products strictly. Citations are provided as a resource for additional applications that have not been validated by Affinity Biosciences. Please choose the appropriate format for each application and consult Materials and Methods sections for additional details about the use of any product in these publications.
For Research Use Only.
Not for use in diagnostic or therapeutic procedures. Not for resale. Not for distribution without written consent. Affinity Biosciences will not be held responsible for patent infringement or other violations that may occur with the use of our products. Affinity Biosciences, Affinity Biosciences Logo and all other trademarks are the property of Affinity Biosciences LTD.